ArticleVeterinary medicine international2026
Histological and Biochemical Assessment of Camel Milk in Protective and Therapeutic Aspirin-Induced Gastric and Liver Damage in Rabbits.
Article in Veterinary medicine international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study aimed to investigate the potential protective effects of camel milk against aspirin-induced gastric mucosal injury. The role of camel milk therapy in improving health status in rabbits was investigated through diagnostic and histological examinations of gastric tissues. All rabbits, 32 New Zealand white rabbits weighing between 1200 and 1800 g and aged between 3 and 5 months, were housed in standard laboratory environments (60% humidity, 20°C-25°C, and typical field rearing), and the animals were randomly divided into four groups, each containing eight rabbits. The control Group S represented the control group, while Group S1 received camel milk (15 mL/day) orally once daily. The Group S2 received a dose of 150 mg/kg body weight (BW) of the drug aspirin once daily oral dose. Whereas the Group S3 received a 15 mL/day dose of camel milk, Group S3 received camel milk 15 mL/day together with aspirin 150 mg/kg BW/day. The drug aspirin was administered once daily. The experiment lasted for a period of 70 days in a controlled environmental laboratory after performing a histopathological examination of the stomach tissues, as well as a biochemical analysis of liver function markers. The incidence and severity of gastric ulcers were significantly reduced in the camel milk-treated group compared to the aspirin group (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.